2024.10.14
Whitepaper_The Advent of Novel Treatment Options for Multiple Myeloma_A Critical Juncture for MM Patients in Korea

리포트 소개


Multiple myeloma (MM) is a rare and complex hematological cancer that causes multi-organ complications and affects patients’ quality of life.

The incidence and prevalence of MM in Korea have been increasing due to improved detection and its ageing population, along with significant increases in the socioeconomic cost of MM in Korea.

In this whitepaper, we discuss the burden of MM in South Korea, the current treatment landscape and novel treatment options, unmet needs, barriers to access of novel MM treatment options and recommendations for the way forward.